| Pharmacokinetics of the CYP3A4 and CYP2B6 inducer carbamazepine and its drug–drug interaction potential: a physiologically based pharmacokinetic modeling approach LM Fuhr, FZ Marok, N Hanke, D Selzer, T Lehr Pharmaceutics 13 (2), 270, 2021 | 32 | 2021 |
| Novel models for the prediction of drug–gene interactions D Türk, LM Fuhr, FZ Marok, S Rüdesheim, A Kühn, D Selzer, M Schwab, ... Expert Opinion on Drug Metabolism & Toxicology 17 (11), 1293-1310, 2021 | 13 | 2021 |
| Physiologically based pharmacokinetic modeling of bupropion and its metabolites in a CYP2B6 drug-drug-gene interaction network FZ Marok, LM Fuhr, N Hanke, D Selzer, T Lehr Pharmaceutics 13 (3), 331, 2021 | 12 | 2021 |
| A physiologically based pharmacokinetic and Pharmacodynamic model of the CYP3A4 substrate Felodipine for drug–drug interaction modeling LM Fuhr, FZ Marok, M Mees, F Mahfoud, D Selzer, T Lehr Pharmaceutics 14 (7), 1474, 2022 | 7 | 2022 |
| A physiologically based pharmacokinetic model of ketoconazole and its metabolites as drug–drug interaction perpetrators FZ Marok, JG Wojtyniak, LM Fuhr, D Selzer, M Schwab, J Weiss, ... Pharmaceutics 15 (2), 679, 2023 | 4 | 2023 |
| Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network D Feick, S Rüdesheim, FZ Marok, D Selzer, HLH Loer, D Teutonico, ... CPT: Pharmacometrics & Systems Pharmacology 12 (8), 1143-1156, 2023 | 3 | 2023 |
| Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6, 7‐Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit‐Drug Interactions LM Fuhr, FZ Marok, U Fuhr, D Selzer, T Lehr Clinical Pharmacology & Therapeutics 114 (2), 470-482, 2023 | 1 | 2023 |
| Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug–drug interaction predictions HLH Loer, C Kovar, S Rüdesheim, FZ Marok, LM Fuhr, D Selzer, ... CPT: Pharmacometrics & Systems Pharmacology, 2024 | | 2024 |
| Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy FZ Marok, JG Wojtyniak, D Selzer, R Dallmann, JJ Swen, HJ Guchelaar, ... Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| Wo t niak FZ Marok G., Selzer, D., Dallmann, R., Swen,.., Guchelaar, H..,… Lehr, 0 | | |
